GROSSMAN ERIC F

Morgan Stanley CLO Eric Grossman sold 11,118 shares for $2,120,758.50 on 2026-04-20 at blended $190.75, reducing holdings by 6.2%.

Eric Grossman, Chief Legal/Admin Officer, executed two separate sales totaling 11,118 shares for $2,120,758.50 on April 20, 2026, at prices of $190.00 and $191.50, leaving him with 169,402 shares post-transaction. The sales occurred near the 52-week high of $191.62, with current price at $190.70, positioning the trades within 0.5% of the yearly peak. Among his prior five sales at Morgan Stanley, only one was well-timed at the 90-day horizon; the most recent sale on January 20, 2026 showed a 90-day return of +3.6%, and his cross-ticker track record across six prior sells shows an average 90-day return of +5.6% with a 16.67% well-timed rate, indicating mixed execution timing historically. The company's fundamentals remain solid with $18.2B in quarterly revenue, 14.4% annual growth, and a P/E of 15.42, providing no obvious distress signal.

Morgan Stanley CLO Eric Grossman sold 21,555 shares at $184.00; retains 168,510 shares post-transaction.

Eric Grossman, Chief Legal/Admin Officer at Morgan Stanley, sold 21,555 shares (21.6K shares) at $184.00 on 2026-01-20 for $3,966,137.24 ($4.0M), reducing his holdings by 11.3% from 190,065 shares to 168,510 shares. His prior trades at MS show mixed execution: across 5 prior sales at this ticker, 1 of 5 were well-timed at the 90-day mark, with results ranging from -22.0% (a well-timed sale in Jan 2025) to +29.0% gain (Apr 2025 sale). Stock is trading at $183.05, down 4.3% from the 52-week high of $191.23, and has gained 11.7% over the past 90 days. The company's recent financials show revenue of $18,224,000,000.00 (latest quarter) with 14.1% annual revenue growth and a P/E of 17.98. This sale reflects a substantial reduction in his direct stake but occurs near recent highs and does not materially alter his significant ongoing holdings.

Grossman (Chief Legal/Admin Officer) sold 12,000 MS shares at $141.12 for $1.7M; holds 186.4K post-sale.

Eric F. Grossman sold 12,000 shares of Morgan Stanley at $141.12 on 2025-07-17, reducing his holdings from 198,420 to 186,420 shares (a 6.0% decrease in stake). The stock currently trades at $140.83, near its 52-week high of $144.14 and up 29.0% over 90 days. Grossman's prior four sales at Morgan Stanley show mixed timing results: his 2025-04-15 sale was well-positioned given the subsequent 29.0% 90-day gain, but his 2025-01-21 sale preceded a 22.0% 90-day decline, and his two January 2024 sales saw modest negative returns. The current sale occurs as the stock is at elevated levels within its range, and his cross-ticker track record shows a 25.0% well-timed sell rate across all holdings. Morgan Stanley's fundamentals remain solid with revenue of $17.7B, net income of $4.3B, and annual growth of +14.1%.

Morgan Stanley CLO Grossman sells 10,068 shares at $111.65; stock down 23.6% from 52-week high, post-transaction holdings 199,274 shares.

Chief Legal/Admin Officer Eric F Grossman sold 10,068 shares at $111.65 on 2025-04-15, reducing his stake by 4.8% to 199,274 shares. The sale occurred when MS was trading 23.6% below its 52-week high of $141.08, in the context of a 20.6% decline over the prior 90 days. His cross-ticker track record shows 3 prior sells with a 90-day well-timed rate of 0.00%, indicating a pattern of selling that preceded subsequent stock recoveries rather than declines. At the same ticker, his prior 2 measurable 90-day outcomes were both positive (+2.6% and +4.9%), continuing the pattern of poorly-timed exits. MS fundamentals remain solid with $15.4B quarterly revenue, $3.2B net income, 14.1% annual growth, and a P/E of 11.22, providing no signal of underlying business deterioration.

Morgan Stanley Chief Legal/Admin Officer Eric F. Grossman sold 13,097 shares at $136.20 on 2025-01-21 for $1.8M.

Eric F. Grossman, Chief Legal/Admin Officer, sold 13,097 shares at $136.20, reducing his holdings by -6.2% from 210,541 to 197,444 shares. The sale occurred near the 52-week high (stock at $137.87), with MS trading at $137.80 currently and up 8.4% over the past 30 days and 17.9% over 90 days. Grossman's prior two sales at MS (2024-01-30 and 2024-01-31) both saw subsequent positive 90-day returns of +2.6% and +4.9% respectively, indicating his previous sales at this ticker were not well-timed—the stock rose after he sold. His cross-ticker track record across all tickers shows 2 prior sells with a 0.00% well-timed rate at 90 days, suggesting his historical sells have not preceded declines. This transaction occurs at elevated valuation with the company reporting $15.4B in latest quarterly revenue and a P/E of 19.83, though the broader market context and any material business developments are not apparent from the transaction data alone.